Earn $5,400 And Help Combat Malaria: Bill Gates Foundation-Supported Human Trial Awaits Those Brave Enough To Allow Deliberate Infection

On Tuesday, Alyssa Vance, a poster on X.com, formerly Twitter, highlighted an opportunity for individuals to participate in a human challenge trial aimed at combating malaria.

What Happened: Vance took to Twitter to share information about a human challenge trial where participants can earn $5,400 by willingly being exposed to malaria.

The purpose of this trial is to test the efficacy of a new treatment. The study, named MAM01 Malaria Monoclonal Antibody Trial, is testing the safety and effectiveness of an experimental human monoclonal antibody called MAM01 for preventing malaria.

Participants, who are generally healthy and aged between 18 and 50 years old, will be exposed to the bite of infected mosquitoes to test the protection offered by MAM01. Immediate treatment will be provided if participants develop malaria. The study is being conducted at the University of Maryland School of Medicine, in collaboration with the Gates Foundation.

See Also: Bill Gates Worries We’re Making Same Mistakes Prepping For Next Pandemic, Wants This Done Instead

Why It Matters: Malaria, primarily spread by mosquitoes, has been a longstanding global health concern. Bill Gates has previously emphasized the importance of eradicating malaria, noting that killing mosquitoes could save up to 400,000 lives annually.

In another instance, Gates highlighted that mosquitoes kill more people in a single day than sharks do in a century. The human challenge trial shared by Vance is a significant step in the fight against this deadly disease, offering hope for a potential breakthrough in malaria prevention and treatment.

Read Next: Johnson & Johnson’s Experimental Dengue Pill Shows Efficacy In Animal Studies


Engineered by Benzinga Neuro, Edited by Shivdeep Dhaliwal


The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.


Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechNewsHealth CareMediaGeneralAntibodiesBill GatesGates FoundationmalariaUniversity of Maryland
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!